SURG vs VIV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 21, 2026

SURG

36.2
AI Score
VS
VIV Wins

VIV

62.1
AI Score

Investment Advisor Scores

SURG

36score
Recommendation
SELL

VIV

62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric SURG VIV Winner
Forward P/E 9.4967 12.6904 SURG
PEG Ratio 0.5333 1.0514 SURG
Revenue Growth 291.6% 6.5% SURG
Earnings Growth -77.7% 15.6% VIV
Tradestie Score 36.2/100 62.1/100 VIV
Profit Margin -83.4% 10.3% VIV
Beta 1.00 1.00 Tie
AI Recommendation SELL BUY VIV

Frequently Asked Questions

Based on our detailed analysis, VIV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.